Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone for aluminum phosphide poisoning
IRCT20090627002083N8Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of edaravone in Aluminium phosphide poisoning (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Echocardiography variables, Cardiac arrhythmia and 6 more. Started Nov 2023; status: completed.
02
Drugs
edaravone
03
Conditions
Aluminium phosphide poisoning
Beyond the preview
Go deeper on IRCT20090627002083N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090627002083N8.